Protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats

Molecular Medicine Reports

Volumn 13, Issue 5, 2016, Pages 3953-3960

  Chen, Xueyan ^a   Zhang, Yu ^b   Zhu, Zhongning ^a   Liu, Huanlong ^a   Guo, Huicai ^a   Xiong, Chen ^a   Xie, Kerang ^a   Zhang, Xiaofei ^a   Su, Suwen ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Family Planning Research Institute of Hebei   (China)

Author keywords

Berberine; Doxorubicin; Hepatorenal toxicity; Oxidative damage

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BERBERINE; CATALASE; CHOLESTEROL; DOXORUBICIN; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITROGEN; PROTECTIVE AGENT; SUPEROXIDE DISMUTASE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME BLOOD LEVEL; GENERAL CONDITION; HEPATORENAL TOXICITY; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LIVER FUNCTION; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MALE; MORTALITY; NEPHROTOXICITY; NONHUMAN; RAT; RENAL PROTECTION; SURVIVAL; TISSUE HOMOGENATE; TISSUE LEVEL; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; CHEMICAL AND DRUG INDUCED LIVER INJURY; CHEMICALLY INDUCED; KIDNEY DISEASES; SPRAGUE DAWLEY RAT;

ANIMALS; BERBERINE; CHEMICAL AND DRUG INDUCED LIVER INJURY; DOXORUBICIN; KIDNEY DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84964744617     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5017     Document Type: Article

References (34)

1. Cheng C, Xue W, Diao H, Xia S, Zuo L, He A, Gao F, Huang Z, Chen J and Zhang J: Antitumor activity and toxicological properties of doxorubicin conjugated to [alpha], [beta]-poly [(2-hydroxyethyl)-L-aspartamide] administered intraperitoneally in mice. Anticancer Drugs 21:362-371, 2010.
2. Tangpong J, Miriyala S, Noel T, Sinthupibulyakit C, Jungsuwadee P and St Clair DK: Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana. Neuroscience 175:292-299, 2011.
3. Cardoso S, Santos RX, Carvalho C, Correia S, Pereira GC, Pereira SS, Oliveira PJ, Santos MS, Proença T and Moreira PI: Doxorubicin increases the susceptibility of brain mitochondria to Ca (2+)-induced permeability transition and oxidative damage. Free Radic Biol Med 45:1395-1402, 2008.
4. Kalender Y, Yel M and Kalender S: Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin. Toxicology 209:39-45, 2005.
5. Bárdi E, Bobok I, Voláh A, Kappelmayer J and Kiss C: Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer. Pathol Oncol Res 13:249-253, 2007.
6. Yang XL, Fan CH and Zhu HS: Photo-induced cytotoxicity of malonic acid [C (60)]fullerene derivatives and its mechanism. Toxicol In Vitro 16:41-46, 2002.
7. Badkoobeh P, Parivar K, Kalantar SM, Hosseini SD and Salabat A: Effect of nano-zinc oxide on doxorubicin-induced oxidative stress and sperm disorders in adult male Wistar rats. Iran J Reprod Med 11:355-364, 2013.
8. Li L, Takemura G, Li Y, Miyata S, Esaki M, Okada H, Kanamori H, Khai NC, Maruyama R, Ogino A, et al: Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Circulation 113:535-543, 2006.
9. Yeh YC, Lai HC, Ting CT, Lee WL, Wang LC, Wang KY, Lai HC and Liu TJ: Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol 74:969-980, 2007.
10. Tang LQ, Wang FL, Zhu LN, Lv F, Liu S and Zhang ST: Berberine ameliorates renal injury by regulating G proteins-AC-cAMP signaling in diabetic rats with nephropathy. Mol Biol Rep 40:3913-3923, 2013.
11. Wang Y, Huang Y, Lam KS, Li Y, Wong WT, Ye H, Lau CW, Vanhoutte PM and Xu A: Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res 82:484-492, 2009.
12. Derosa G, Maffioli P and Cicero AF: Berberine on metabolic and cardiovascular risk factors: An analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther 12:1113-1124, 2012.
13. Cho BJ, Im EK, Kwon JH, Lee KH, Shin HJ, Oh J, Kang SM, Chung JH and Jang Y: Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1 2 pathway in vascular smooth muscle cells. Mol Cells 20:429-434, 2005.
14. Li J, Pan Y, Kan M, Xiao X, Wang Y, Guan F, Zhang X and Chen L: Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase. Life Sci 98:24-30, 2014.
15. Hsu YY, Tseng YT and Lo YC: Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth. Toxicol Appl Pharmacol 272:787-796, 2013.
16. Marin-Neto JA, Maciel BC, Secches AL and Gallo Junior L: Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin Cardiol 11:253-260, 1988.
17. Zhao X, Zhang J, Tong N, Liao X, Wang E, Li Z, Luo Y and Zuo H: Berberine attenuates doxorubicin-induced cardiotoxicity in mice. J Int Med Res 39:1720-1727, 2011.
18. Kelishomi RB, Ejtemaeemehr S, Tavangar SM, Rahimian R, Mobarakeh JI and Dehpour AR: Morphine is protective against doxorubicin-induced cardiotoxicity in rat. Toxicology 243:96-104, 2008.
19. Jing L, Wu Y, Wu J, Zhao J, Zuo D and Peng S: Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicity. Eur J Pharmacol 659:224-232, 2011.
20. Hou XW, Jiang Y, Wang LF, Xu HY, Lin HM, He XY, He JJ and Zhang S: Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities. Toxicol Lett 187:40-44, 2009.
21. You JS, Pan TL and Lee YS: Protective effects of Danshen (Salvia miltiorrhiza) on adriamycin-induced cardiac and hepatic toxicity in rats. Phytother Res 21:1146-1152, 2007.
22. Outomuro D, Grana DR, Azzato F and Milei J: Adriamycin-induced myocardial toxicity: New solutions for an ole problems? Int J Cardiol 117:6-15, 2007.
23. Piscitelli SC, Rodvold KA, Rushing DA and Tewksbury DA: Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small-cell lung cancer. Clin Pharmacol Ther 53:555-561, 1993.
24. Swain SM, Whaley FS and Ewer MS: Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer 97:2869-2879, 2003.
25. King SL, Mohiuddin JJ and Dekaney CM: Paneth cells expand from newly created and preexisting cells during repair after doxorubicin-induced damage. Am J Physiol Gastrointest Liver Physiol 305:G151-G162, 2013.
26. Tong N, Zhang J, Chen Y, Li Z, Luo Y, Zuo H and Zhao X: Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncol Lett 3:1263-1267, 2012.
27. Abd El-Wahab AE, Ghareeb DA, Sarhan EE, Abu-Serie MM and El Demellawy MA: In vitro biological assessment of Berberis vulgaris and its active constituent, berberine: Antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complement Altern Med 13:218, 2013.
28. Yan K, Zhang C, Feng J, Hou L, Yan L, Zhou Z, Liu Z, Liu C, Fan Y, Zheng B and Xu Z: Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur J Pharmacol 661:1-7, 2011.
29. Youn MJ, So HS, Cho HJ, Kim HJ, Kim Y, Lee JH, Sohn JS, Kim YK, Chung SY and Park R: Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria caspase-mediated pathway in HeLa cells. Biol Pharm Bull 31:789-795, 2008.
30. Hsu YY, Chen CS, Wu SN, Jong YJ and Lo YC: Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase Akt-dependent mechanism in NSC34 motor neuron-like cells. Eur J Pharm Sci 46:415-425, 2012.
31. Lv XX, Yu XH, Wang HD, Yan YX, Wang YP, Lu DX, Qi RB, Hu CF and Li HM: Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-α-caspase signaling pathway. Chin J Integr Med 19:424-431, 2013.
32. Cheng F, Wang Y, Li J, Su C, Wu F, Xia WH, Yang Z, Yu BB, Qiu YX and Tao J: Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol 167:936-942, 2013.
33. Shen L and Ji HF: The mechanisms of ROS-photogeneration by berberine, a natural isoquinoline alkaloid. J Photochem Photobiol B 99:154-156, 2010.
34. Zhao X, Zhang J, Tong N, Chen Y and Luo Y: Protective effects of berberine on doxorubicin-induced hepatotoxicity in mice. Biol Pharm Bull 35:796-800, 2012.